Perampanel in lissencephaly-associated epilepsy.

التفاصيل البيبلوغرافية
العنوان: Perampanel in lissencephaly-associated epilepsy.
المؤلفون: Ikemoto S; Division of Neurology, Saitama Children's Medical Center, 2-1 Shin-toshin, Chuou-ku, Saitama-city, Saitama 330-8777, Japan.; Department of Pediatrics, The Jikei University School of Medicine, 3-19-18 Nishi-shinbashi, Minato-ku, Tokyo 105-8471, Japan., Hamano SI; Division of Neurology, Saitama Children's Medical Center, 2-1 Shin-toshin, Chuou-ku, Saitama-city, Saitama 330-8777, Japan.; Department for Child Health and Human Development, Saitama Children's Medical Center, 2-1 Shin-toshin, Chuou-ku, Saitama-city, Saitama 330-8777, Japan., Hirata Y; Division of Neurology, Saitama Children's Medical Center, 2-1 Shin-toshin, Chuou-ku, Saitama-city, Saitama 330-8777, Japan.; Department of Pediatrics, The Jikei University School of Medicine, 3-19-18 Nishi-shinbashi, Minato-ku, Tokyo 105-8471, Japan., Matsuura R; Division of Neurology, Saitama Children's Medical Center, 2-1 Shin-toshin, Chuou-ku, Saitama-city, Saitama 330-8777, Japan., Koichihara R; Department for Child Health and Human Development, Saitama Children's Medical Center, 2-1 Shin-toshin, Chuou-ku, Saitama-city, Saitama 330-8777, Japan.
المصدر: Epilepsy & behavior case reports [Epilepsy Behav Case Rep] 2019 Jan 11; Vol. 11, pp. 67-69. Date of Electronic Publication: 2019 Jan 11 (Print Publication: 2019).
نوع المنشور: Case Reports
اللغة: English
بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101614202 Publication Model: eCollection Cited Medium: Print ISSN: 2213-3232 (Print) Linking ISSN: 22133232 NLM ISO Abbreviation: Epilepsy Behav Case Rep Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: [New York] : Elsevier Inc., 2013-2019.
مستخلص: We retrospectively investigated whether perampanel (PER) could serve as an alternative for treating drug-resistant seizures in lissencephaly. We investigated the following data: age at onset of epilepsy, age at start of PER, etiology, brain MRI findings, seizure type, seizure frequency, adverse effects, and concomitant anti-epileptic drugs. There were 5 patients with lissencephaly, including 2 with Miller-Dieker syndrome. Four out of five patients exhibited ≥ 50% seizure reduction. Myoclonic seizures disappeared in 1 patient. PER was an effective adjunctive anti-seizure drug in our series of patients with lissencephaly.
References: J Neurosci. 2006 May 31;26(22):5901-9. (PMID: 16738232)
Dev Neurosci. 2008;30(1-3):105-16. (PMID: 18075259)
Epilepsy Curr. 2011 Mar;11(2):56-63. (PMID: 21686307)
CNS Drugs. 2012 Dec;26(12):1085-96. (PMID: 23179642)
Eur J Neurosci. 2013 May;37(9):1369-82. (PMID: 23383979)
Brain Dev. 2016 Apr;38(4):399-406. (PMID: 26494205)
Epilepsy Behav. 2016 Sep;62:132-5. (PMID: 27459034)
Epilepsia. 2017 Apr;58(4):543-547. (PMID: 28166365)
Epilepsia. 2017 Nov;58(11):1985-1992. (PMID: 28850671)
Epilepsy Behav Case Rep. 2017 May 26;8:44-46. (PMID: 28856097)
Ann Neurol. 1999 Feb;45(2):154-61. (PMID: 9989616)
فهرسة مساهمة: Keywords: AMPA, alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid; DRPLA, dentatorubral–pallidoluysian atrophy; GTCS, generalized tonic–clonic seizures; Lissencephaly; NMDA, N-methyl-d-aspartate; Neuronal migration disorder; PER, perampanel; Perampanel
تواريخ الأحداث: Date Created: 20190207 Latest Revision: 20201001
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC6351285
DOI: 10.1016/j.ebcr.2019.01.001
PMID: 30723672
قاعدة البيانات: MEDLINE
الوصف
تدمد:2213-3232
DOI:10.1016/j.ebcr.2019.01.001